Clinical Trial Update: Metronidazole for Pulmonary Tuberculosis (South Korea) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metronidazole for pulmonary tuberculosis, including multidrug-resistant TB. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, Multi-Drug Resistant Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2013-07-10